$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

$cpsh Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924015003 Filed on May 07, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$5.030M	$5.913M
YoY Change	-29.15%
Cost Of Revenue	$5.260M	$5.006M
YoY Change	8.34%
Gross Profit	-$230.0K	$906.3K
YoY Change	-110.25%
Gross Profit Margin	-4.57%	15.33%
Selling, General & Admin	$1.085M	$1.166M
YoY Change	-30.02%
% of Gross Profit		128.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$136.5K	$101.4K
YoY Change	9.58%
% of Gross Profit		11.19%
Operating Expenses	$1.085M	$1.166M
YoY Change	-30.02%
Operating Profit	-$1.315M	-$259.6K
YoY Change	-289.43%
Interest Expense	$90.85K	-$830.00
YoY Change	-5999.35%
% of Operating Profit
Other Income/Expense, Net		$79.17K
YoY Change
Pretax Income	-$1.224M	-$180.4K
YoY Change	-272.47%
Income Tax	-$269.8K	-$37.29K
% Of Pretax Income
Net Earnings	-$954.3K	-$143.2K
YoY Change	-307.82%
Net Earnings / Revenue	-18.97%	-2.42%
Basic Earnings Per Share	-$0.07	-$0.01
Diluted Earnings Per Share	-$0.07	-$0.01
COMMON SHARES
Basic Shares Outstanding	14.52M	14.52M
Diluted Shares Outstanding	14.52M	14.52M

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.056M	$8.668M
YoY Change	-4.26%
Cash & Equivalents	$6.306M	$8.668M
Short-Term Investments	$750.0K
Other Short-Term Assets	$366.7K	$392.0K
YoY Change	22.38%
Inventory	$4.122M	$4.611M
Prepaid Expenses
Receivables	$4.064M	$3.849M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$15.82M	$17.55M
YoY Change	-11.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.134M	$1.718M
YoY Change	54.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.877M	$1.610M
YoY Change	1.86%
Total Long-Term Assets	$4.272M	$3.625M
YoY Change	16.89%
TOTAL ASSETS
Total Short-Term Assets	$15.82M	$17.55M
Total Long-Term Assets	$4.272M	$3.625M
Total Assets	$20.09M	$21.17M
YoY Change	-6.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.588M	$2.410M
YoY Change	26.43%
Accrued Expenses	$671.9K	$843.8K
YoY Change	-8.15%
Deferred Revenue	$65.58K	$207.2K
YoY Change	-96.41%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$31.89K	$43.48K
YoY Change	-28.21%
Total Short-Term Liabilities	$3.517M	$3.664M
YoY Change	-26.84%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%
Other Long-Term Liabilities	$132.3K	$168.3K
YoY Change	-52.07%
Total Long-Term Liabilities	$132.3K	$168.3K
YoY Change	-58.59%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.517M	$3.664M
Total Long-Term Liabilities	$132.3K	$168.3K
Total Liabilities	$3.649M	$3.833M
YoY Change	-28.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$23.85M	-$22.90M
YoY Change	0.79%
Common Stock	$146.0K	$146.0K
YoY Change	0.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$250.1K	$250.1K
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.44M	$17.34M
YoY Change
Total Liabilities & Shareholders Equity	$20.09M	$21.17M
YoY Change	-6.27%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$954.3K	-$143.2K
YoY Change	-307.82%
Depreciation, Depletion And Amortization	$136.5K	$101.4K
YoY Change	9.58%
Cash From Operating Activities	-$1.048M	$128.9K
YoY Change	45.68%
INVESTING ACTIVITIES
Capital Expenditures	$552.4K	$263.3K
YoY Change	212.75%
Acquisitions
YoY Change
Other Investing Activities	-$750.0K
YoY Change
Cash From Investing Activities	-$1.302M	-$263.3K
YoY Change	637.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.59K	-$11.41K
YoY Change	865.03%
NET CHANGE
Cash From Operating Activities	-1.048M	$128.9K
Cash From Investing Activities	-1.302M	-$263.3K
Cash From Financing Activities	-11.59K	-$11.41K
Net Change In Cash	-2.361M	-$145.9K
YoY Change	163.3%
FREE CASH FLOW
Cash From Operating Activities	-$1.048M	$128.9K
Capital Expenditures	$552.4K	$263.3K
Free Cash Flow	-$1.600M	-$134.5K
YoY Change	78.62%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-28
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14601487
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14601487
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14519215
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14519215
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	82272
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	82272
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-231367	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-30
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	0-16088
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-2832509
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	111 South Worcester Street
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Norton
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02766-2102
CY2024Q1	dei	City Area Code CityAreaCode	508
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	222-0614
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2024Q1	dei	Trading Symbol TradingSymbol	CPSH
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14519215
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8667728	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8813626	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3848635	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4389155	usd
CY2024Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	27490	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	83191	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	4611460	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4581930	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	391953	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	276349	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	17547266	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	18144251	usd
CY2024Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	11155183	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	11271982	usd
CY2024Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	952883	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	952883	usd
CY2024Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	985649	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	985649	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13093715	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13210514	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11581885	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11936004	usd
CY2024Q1	cpsh	Construction In Progress Net ConstructionInProgressNet	206250	usd
CY2023Q4	cpsh	Construction In Progress Net ConstructionInProgressNet	281629	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1718080	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1556139	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	297000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	332000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1609982	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1569726	usd
CY2024Q1	us-gaap	Assets Assets	21172328	usd
CY2023Q4	us-gaap	Assets Assets	21602116	usd
CY2024Q1	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	43478	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	46797	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2409773	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2535086	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	843770	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1075137	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	207247	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	251755	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	160000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	160000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3664268	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4068775	usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	8090	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	31277	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	31277	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	137000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	172000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	3832545	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4280142	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	146015	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	146015	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40341855	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40180893	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22897949	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22754796	usd
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	250138	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	250138	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	17339783	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	17321974	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21172328	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21602116	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5912634	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7100267	usd
CY2024Q1	us-gaap	Revenues Revenues	5912634	usd
CY2023Q2	us-gaap	Revenues Revenues	7100267	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5006324	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4855564	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	906310	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	2244703	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1165922	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1550522	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-259612	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	694181	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	79171	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15590	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-180441	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	709771	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-37288	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	250570	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-143153	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	459201	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14519215
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14452284
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14519215
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14639600
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	17321974	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	160962	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-143153	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	17339783	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15705516	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	130441	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9495	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	459201	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	16304653	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-143153	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	459201	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	101405	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	124608	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	160962	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	130441	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-540520	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	936163	usd
CY2024Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-55701	usd
CY2023Q2	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	15035	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	29530	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-183246	usd
CY2024Q1	cpsh	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	115604	usd
CY2023Q2	cpsh	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	88359	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-125313	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	210028	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-89402	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	40256	usd
CY2023Q2	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-226444	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-44508	usd
CY2023Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-924080	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	128857	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-719071	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	263346	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	176618	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-263346	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-176618	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9495	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	11409	usd
CY2023Q2	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	10696	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11409	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1201	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-145898	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-896890	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8813626	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8266753	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8667728	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7369863	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	825	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	1538	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023Q2	us-gaap	Stock Issued1 StockIssued1	790	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-143153	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	459201	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-143153	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	459201	usd
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	187316
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14519215
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14639600
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2024Q1	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	38000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	124000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	165000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	28000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	317000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	20000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	297000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	160000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	137000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	297000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P23Y
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.066	pure
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	7001
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.47
CY2024Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2023Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	285
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1097900
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.61
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y21D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	582800
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.44
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y3M18D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1004400
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.51
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1500000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	638300
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	693000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y5M8D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	161000	usd
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	130000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	2745792	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2861333	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1577574	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1493582	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	616054	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	537975	usd
CY2024Q1	us-gaap	Inventory Gross InventoryGross	4939420	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	4892890	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	327960	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	310960	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	4611460	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4581930	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	57460	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	86000	usd
CY2024Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	387271	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	649201	usd
CY2024Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	399039	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	339936	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	843770	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1075137	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	35388	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	8090	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	43478	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	825	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1538	usd
CY2024Q1	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	40	usd

Files In Submission

Name	View Source	Status
0001437749-24-015003-index-headers.html	Edgar Link	pending
0001437749-24-015003-index.html	Edgar Link	pending
0001437749-24-015003.txt	Edgar Link	pending
0001437749-24-015003-xbrl.zip	Edgar Link	pending
cpsh-20240330.xsd	Edgar Link	pending
cpsh-20240330_cal.xml	Edgar Link	unprocessable
cpsh20240330_10q.htm	Edgar Link	pending
ex_664851.htm	Edgar Link	pending
ex_664852.htm	Edgar Link	pending
ex_664853.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cpsh-20240330_lab.xml	Edgar Link	unprocessable
cpsh-20240330_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cpsh20240330_10q_htm.xml	Edgar Link	completed
cpsh-20240330_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

2024 Q2 Form 10-Q Financial Statement

#000143774924015003 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSH CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

2024 Q2 Form 10-Q Financial Statement

#000143774924015003 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh